IMBdx

Share · KR7461030009 (XKOS)

Overview

No Price

Closing Price XKOS 20.03.2026: 6.870,00 KRW

20.03.2026 06:30

Current Prices from IMBdx

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
KOSDAQ	461030.KQ	KRW	20.03.2026 06:30	6.870,00 KRW	210,00 KRW +3,15 %

Share Float & Liquidity

Free Float 36,18 %

Shares Float 5,07 M

Shares Outstanding 14,02 M

Company Profile for IMBdx Share

IMBdx, Inc. engages in the development of liquid biopsy tests for cancer diagnosis. It focuses on the following business areas: diagnosis and treatment of advanced cancer, early detection of recurrence after surgery, and early cancer diagnosis. Its products include AlphaLiquid, CancerDetect, and CancerFind. The company was founded by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018 and is headquartered in Seoul, South Korea.

AI Analysis of IMBdx

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of IMBdx

No AI threads available for this company yet.

Company Data

Name IMBdx

Company IMBdx

Website http://www.imbdx.com

Primary Exchange

KOSDAQ

ISIN KR7461030009

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Tae-You Kim

Market Capitalization 96 Mrd.

Country South Korea

Currency KRW

Employees 0,1 T

Address BYC Highcity Bldg A, Seoul

IPO Date 2024-04-01

Ticker Symbols

Name	Symbol
KOSDAQ	461030.KQ

More Shares

Investors who hold IMBdx also have the following shares in their portfolio:

BROOKFI.FIN. 24/54 Bond

PERMANENT MASTER ISSUER PLC SERIES 2 CLSB AST BKD FRN 15/07/42 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog